BDBM165384 US9062043, Table 13, Compound 52::US9062043, Table 20b, Compound 25

SMILES: COCCNc1ncc2c3ccc(cc3nc(Nc3cccc(c3)C#C)c2n1)C(O)=O

InChI Key: InChIKey=ZXKCTFWBTFMJKT-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 165384   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Casein kinase II subunit alpha (Homo sapiens (Human))	BDBM165384 (US9062043, Table 13, Compound 52 | US9062043, Tabl...) Show SMILES COCCNc1ncc2c3ccc(cc3nc(Nc3cccc(c3)C#C)c2n1)C(O)=O Show InChI InChI=1S/C23H19N5O3/c1-3-14-5-4-6-16(11-14)26-21-20-18(13-25-23(28-20)24-9-10-31-2)17-8-7-15(22(29)30)12-19(17)27-21/h1,4-8,11-13H,9-10H2,2H3,(H,26,27)(H,29,30)(H,24,25,28)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	7.2	n/a
SENHWA BIOSCIENCES, INC. US Patent					Assay Description Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...				US Patent US9062043 (2015) BindingDB Entry DOI: 10.7270/Q20G3HWF
					More data for this Ligand-Target Pair
Casein kinase II subunit alpha (Homo sapiens (Human))	BDBM165384 (US9062043, Table 13, Compound 52 | US9062043, Tabl...) Show SMILES COCCNc1ncc2c3ccc(cc3nc(Nc3cccc(c3)C#C)c2n1)C(O)=O Show InChI InChI=1S/C23H19N5O3/c1-3-14-5-4-6-16(11-14)26-21-20-18(13-25-23(28-20)24-9-10-31-2)17-8-7-15(22(29)30)12-19(17)27-21/h1,4-8,11-13H,9-10H2,2H3,(H,26,27)(H,29,30)(H,24,25,28)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.4	n/a
SENHWA BIOSCIENCES, INC. US Patent					Assay Description The human leukemia Jurkat T-cell line was maintained in RPMI 1640 (Cambrex) supplemented with 10% fetal calf serum and 50 ng/ml Geutamycin. Before tr...				US Patent US9062043 (2015) BindingDB Entry DOI: 10.7270/Q20G3HWF
					More data for this Ligand-Target Pair